AURA
Price
$6.50
Change
+$0.40 (+6.56%)
Updated
Jun 6 closing price
Capitalization
403.03M
61 days until earnings call
CASI
Price
$1.86
Change
-$0.01 (-0.53%)
Updated
Jun 6 closing price
Capitalization
28.85M
Interact to see
Advertisement

AURA vs CASI

Header iconAURA vs CASI Comparison
Open Charts AURA vs CASIBanner chart's image
Aura Biosciences
Price$6.50
Change+$0.40 (+6.56%)
Volume$178.26K
Capitalization403.03M
CASI Pharmaceuticals
Price$1.86
Change-$0.01 (-0.53%)
Volume$3.89K
Capitalization28.85M
AURA vs CASI Comparison Chart
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. CASI commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Buy and CASI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (AURA: $6.50 vs. CASI: $1.86)
Brand notoriety: AURA and CASI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 80% vs. CASI: 34%
Market capitalization -- AURA: $403.03M vs. CASI: $28.85M
AURA [@Biotechnology] is valued at $403.03M. CASI’s [@Biotechnology] market capitalization is $28.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileCASI’s FA Score has 0 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • CASI’s FA Score: 0 green, 5 red.
According to our system of comparison, AURA is a better buy in the long-term than CASI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 6 TA indicator(s) are bullish while CASI’s TA Score has 4 bullish TA indicator(s).

  • AURA’s TA Score: 6 bullish, 3 bearish.
  • CASI’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AURA is a better buy in the short-term than CASI.

Price Growth

AURA (@Biotechnology) experienced а +10.92% price change this week, while CASI (@Biotechnology) price change was -1.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

AURA is expected to report earnings on Aug 07, 2025.

CASI is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($403M) has a higher market cap than CASI($28.8M). AURA YTD gains are higher at: -20.925 vs. CASI (-34.208). CASI has higher annual earnings (EBITDA): -31.62M vs. AURA (-91.84M). AURA has more cash in the bank: 174M vs. CASI (20.8M). AURA (19.1M) and CASI (19.1M) have identical debt. CASI has higher revenues than AURA: CASI (22.1M) vs AURA (0).
AURACASIAURA / CASI
Capitalization403M28.8M1,399%
EBITDA-91.84M-31.62M290%
Gain YTD-20.925-34.20861%
P/E RatioN/AN/A-
Revenue022.1M-
Total Cash174M20.8M837%
Total Debt19.1M19.1M100%
FUNDAMENTALS RATINGS
CASI: Fundamental Ratings
CASI
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AURACASI
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
72%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCL276.344.94
+1.82%
Royal Caribbean Group
HXL56.390.54
+0.97%
Hexcel Corp
ALEX18.150.11
+0.61%
Alexander & Baldwin
VOR0.22N/A
+0.09%
Vor Biopharma
AFRI7.83-0.03
-0.38%
Forafric Global PLC